Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 17/20 | 0.48 |
| ▸ | KHK | P50053 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2214450 | 0.89 | MAPK14 (0.46) | MAPK14KHKCYP3A4CYP2C9MAPK11 | |
| SCHEMBL1384078 | 0.85 | MAPK14 (0.51) | MAPK14KHKCYP3A4CYP2C9MAPK11 | |
| SCHEMBL2218495 | 0.84 | MAPK14 (0.48) | MAPK14CYP3A4CYP2C9MAPK11 | |
| SCHEMBL1417107 | 0.83 | MAPK14 (0.51) | MAPK14KHKCYP3A4CYP2C9MAPK11 | |
| SCHEMBL1382689 | 0.82 | MAPK14 (0.49) | MAPK14KHKCYP3A4CYP2C9MAPK11 | |
| SCHEMBL1385810 | 0.81 | MAPK14 (0.47) | MAPK14KHKCYP3A4CYP2C9MAPK11 | |
| SCHEMBL12936022 | 0.78 | MAPK14 (0.47) | MAPK14KHKCYP3A4CYP2C9MAPK11 | |
| SCHEMBL2216787 | 0.77 | MAPK14 (0.48) | MAPK14CYP3A4CYP2C9MAPK11 | |
| SCHEMBL11965677 | 0.77 | MAPK14 (0.54) | MAPK14CYP3A4CYP2C9MAPK11 | |
| SCHEMBL11996696 | 0.76 | MAPK14 (0.44) | MAPK14KHKCYP3A4CYP2C9MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1641764-B1 | 5-MEMBERED HETEROCYCLE-BASED P38 KINASE INHIBITORS | NOVARTIS AG (CH) | 2011-07-27 | — | — | EP | claimed |